FDA clears Abbott glucose-monitoring tool

The FDA has granted Abbott Laboratories approval to market its FreeStyle Navigator system, designed to continuously monitor the blood-sugar levels of diabetics. The device, which was cleared by European regulators last June, will be available in the second quarter of 2008 by prescription.

View Full Article in:

Chicago Sun-Times (free registration) · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI